Sign in

Jason Klurfeld

General Counsel and Corporate Secretary at EvercoreEvercore
Executive

About Jason Klurfeld

Jason Klurfeld (age 52) is Evercore’s General Counsel and Corporate Secretary, responsible for legal and compliance; he joined Evercore in June 2011 and was appointed General Counsel in February 2018. He previously practiced M&A and corporate law at Sullivan & Cromwell (2006–2011) and Skadden Arps (2004–2006), and served as an aide to Senator Daniel Patrick Moynihan. He holds a B.A. in economics (Hamilton College), a Master’s in History (Oxford – St. Antony’s), and a J.D. (University of Pennsylvania) . Company performance context for his 2024 incentive decision: Adjusted Net Revenues $3.003B (vs. $2.449B in 2023), Adjusted EPS $9.42, Adjusted Net Income $415.8M, and Adjusted Operating Margin 18.6% . Evercore’s $100 TSR value grew to $417 for the 2019–2024 period, reflecting strong multi‑year shareholder returns .

Past Roles

OrganizationRoleYearsStrategic impact
Sullivan & Cromwell LLPCorporate/transactional attorney (M&A, financings, investments)2006–2011Advised on complex M&A/financing; foundation for GC role at Evercore
Skadden, Arps, Slate, Meagher & Flom LLPCorporate/transactional attorney2004–2006Large‑scale deal execution experience

External Roles

OrganizationRoleYearsNotes
Not disclosedThe proxy contains no disclosure of external directorships/roles for Mr. Klurfeld

Fixed Compensation

Component2024Notes
Base salary$500,000Base salaries for NEOs have not increased since becoming executive officers
Special deferred cash (2018 grant)$1.5M total; vesting: $210k each on Feb 13, 2022–2026; $225k each on Feb 13, 2027–2028Accelerates on change in control, death/disability, or termination without cause (subject to release); paid ~2.5 months post‑vest

Performance Compensation

  • Design: No guaranteed bonuses; 50% cash and 50% RSUs for 2024, with RSUs vesting over 4 years. Incentives are discretionary, informed by firm performance and individual contributions (no formulaic weights) .
  • 2024 award: $4.50M total (Cash $2.25M; RSUs $2.25M), recognizing leadership of global compliance, regulatory response, corporate governance, recruiting and geographic expansion; risk management in partnership with CFO .
MetricWeightingTarget2024 ActualPayout linkageVesting terms
Adjusted Net RevenuesDiscretionary (no fixed weight)None pre‑set$3,003MIncorporated holistically into 2024 incentiveRSUs deliver ratably over 4 years
Adjusted EPSDiscretionaryNone pre‑set$9.42Incorporated holisticallyRSUs deliver over 4 years
Adjusted Net IncomeDiscretionaryNone pre‑set$415.8MIncorporated holisticallyRSUs deliver over 4 years
Adjusted Operating MarginDiscretionaryNone pre‑set18.6%Incorporated holisticallyRSUs deliver over 4 years
Individual performanceDiscretionaryN/ASee narrative (compliance, governance, recruiting, expansion)$4.50M total (50% cash; 50% RSUs)4‑year RSU delivery

Multi‑Year Compensation (Committee view of annual pay decisions)

YearSalary ($)Cash Incentive ($)RSUs ($)Total ($)
2022500,0001,875,0001,875,0004,250,000
2023500,0001,875,0001,875,0004,250,000
2024500,0002,250,0002,250,0005,000,000

Note: Summary Compensation Table differs due to SEC grant‑date timing and inclusion of deferred‑cash vesting; see SCT for 2022–2024 reported values .

Equity Ownership & Alignment

ItemDetail
Beneficial ownership6,583 Class A shares; 1,200 Voting Units (LP units) – each <1% of class
Unvested RSUs (12/31/24)32,007 RSUs; aggregated market value $8,872,020 at $277.19 close
Upcoming vesting schedule9,128 (2/4/2026); 731 (2/13/2026); 6,202 (2/4/2027); 782 (2/13/2027); 2,660 (2/4/2028); 783 (2/13/2028)
Ownership guidelinesSMD guideline: lesser of 40,000 shares or 50% of RSUs granted over last 4 years; all NEOs met guidelines for 2024
Hedging/pledgingHedging prohibited; pledging prohibited for directors/executive officers without Committee approval
ClawbacksNYSE‑compliant clawback covering incentive‑based comp for 3 fiscal years preceding a restatement; additional SMD misconduct/restatement clawback also maintained

Employment Terms

TopicTerms (Mr. Klurfeld)
Employment statusAt‑will
Non‑competeWhile employed (no post‑employment non‑compete)
Non‑solicitEmployees/consultants: 12 months; certain actual/prospective clients: 6 months after termination
Annual RSUs (bonus equity)4‑year ratable delivery; accelerated on change in control, death, disability, qualifying retirement, or termination without cause (with release)
Special equity grantOne‑time 30,000 RSUs (granted Mar 10, 2025); cliff‑vest on 4th anniversary; full acceleration on change in control, death/disability, or termination without cause/for good reason
Deferred cash (2018)$1.5M with scheduled vesting; accelerates on change in control, death/disability, or termination without cause (with release)
Potential payouts (12/31/24 assumptions)On change in control, death/disability, or termination without cause: accelerated vesting of equity ($8.872M) and deferred cash ($0.870M) (values at $277.19)
PerquisitesPerquisites < $10,000; thus not itemized for NEOs

Performance & Track Record (role‑relevant highlights)

  • 2024 contributions cited by the Committee: enhanced global compliance policies, timely regulatory response, corporate governance liaison with lead shareholders, leadership in recruiting and geographic expansion, and firmwide operational/reputational risk management with the CFO .
  • Company results used in pay context: Net Revenues (GAAP $2.98B; Adjusted $3.00B), Net Income (GAAP $378.3M; Adjusted $415.8M), EPS (GAAP $9.08; Adjusted $9.42), Operating Margin (GAAP 17.7%; Adjusted 18.6%) .
  • Shareholder returns: $100 investment in 2019 grew to $417 by 2024, outpacing peer average index cited in the proxy .

Vesting Schedules and Potential Selling Pressure

Vest dateRSUs scheduled to vest
Feb 4, 20269,128
Feb 13, 2026731
Feb 4, 20276,202
Feb 13, 2027782
Feb 4, 20282,660
Feb 13, 2028783

Reference value context: total unvested RSUs for Mr. Klurfeld were valued at $8.872M as of 12/31/24 using $277.19/share; actual liquidity windows will depend on trading plans and company insider‑trading policy .

Compensation Structure Analysis

  • Cash vs equity mix: Roughly half of 2024 incentive in RSUs with 4‑year delivery (more at‑risk, longer horizon; supportive of retention) .
  • Shift in risk: Evercore does not use stock options; RSUs are used to align executives with absolute share performance (downside‑sensitive) .
  • Discretion and metrics: No formulaic weights or targets; Committee evaluates Adjusted Net Revenues, Adjusted EPS, Adjusted Net Income, and Adjusted Operating Margin holistically alongside qualitative leadership and risk stewardship .
  • Anti‑dilution posture: Company repurchases to offset dilution from equity awards; $590.6M returned in 2024 through dividends and buybacks .

Governance, Policies, and Red Flags

  • Hedging/pledging prohibited for executives; ownership guidelines met by all NEOs in 2024 (alignment positive) .
  • Clawbacks in place (NYSE‑compliant plus additional SMD policy) .
  • No tax gross‑ups disclosed for Mr. Klurfeld (contrast: Altman has a potential excise‑tax gross‑up) .
  • Say‑on‑Pay support ~93% in prior year, with no material program changes – indicates investor acceptance of pay model .

Investment Implications

  • Alignment/retention: Significant unvested equity ($8.9M at 12/31/24) with multi‑year delivery, plus a 30,000‑RSU special grant vesting in 2029, reduce near‑term departure risk and align incentives with long‑term TSR and EPS compounding .
  • Selling pressure: Clear vesting calendar through 2028; monitor Form 4s around scheduled February vesting windows for potential incremental supply (company has offset dilution historically) .
  • Governance quality: Robust anti‑hedging/pledging, ownership guidelines, and clawback policies, combined with strong Say‑on‑Pay results, support investor confidence in incentive integrity .
  • Pay‑for‑performance transparency: Discretionary framework relies on holistic metrics; while flexible, it provides less ex‑ante visibility. However, the equity‑heavy structure with four‑year delivery and strong firm results mitigate concerns about weak pay‑performance linkage .